/Investor DB

TruVenturo GmbH — 2020 Investments

1 investments dated 2020 · listed companies and verified rows first · show all

CereGateceregate.cominSep 2020

Ceregate develops brain-computer interface and neuromodulation technologies to improve patient outcomes in neurodisorders.

AI & Machine LearningDeep TechHealthtechMedical Devices

Matthias Puls(CEO)inBrian Blischak(President)in

Co-investorsCARMA FUNDHeal CapitalHigh Tech Gruenderfonds468 CapitalHTGF

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.